Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
D000995:Antitubercular Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D007202:Indicators and Reagents; D008826:Microbial Sensitivity Tests; D009025:Morpholines / Q000138:chemical synthesis* / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010879:Piperazines / Q000138:chemical synthesis* / Q000494:pharmacology*; D010880:Piperidines / Q000138:chemical synthesis* / Q000494:pharmacology*; D013844:Thiazoles / Q000138:chemical synthesis* / Q000494:pharmacology*; D014230:Triazoles / Q000138:chemical synthesis* / Q000494:pharmacology*
C482665:5-(5-nitro-2-thienyl)-2-(morpholinyl)-1,3,4-thiadiazole; C482667:5-(5-nitro-2-thienyl)-2-(piperazinyl)-1,3,4-thiadiazole; C482666:5-(5-nitro-2-thienyl)-2-(piperidinyl)-1,3,4-thiadiazole; D000995:Antitubercular Agents; D007202:Indicators and Reagents; D009025:Morpholines; D010879:Piperazines; D010880:Piperidines; D013844:Thiazoles; D014230:Triazoles